Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 8 (August)

1. Follow-up in patients with localised primary cutaneous melanoma.
   Lancet Oncol, 6(8): 608-21. [Abstract] [Full-text]
2. The cyclin-dependent kinase 11 interacts with NOT2.
   Biochem Biophys Res Commun, 334(4): 1310-6. [Abstract] [Full-text]
3. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice.
   Cancer Res, 65(15): 7007-12. [Abstract] [Full-text]
4. Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells.
   Hum Gene Ther, 16(8): 996-1005. [Abstract] [Full-text]
5. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.
   Proc Natl Acad Sci U S A, 102(31): 11041-6. [Abstract] [Full-text]
6. Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.
   Int J Cancer, 116(6): 944-8. [Abstract] [Full-text]
7. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
   Int J Cancer, 116(6): 909-13. [Abstract] [Full-text]
8. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.
   Br J Cancer, 93(3): 273-8. [Abstract] [Full-text]
9. Discriminating nevus and melanoma on paraffin-embedded skin biopsies using FTIR microspectroscopy.
   Biochim Biophys Acta, 1724(3): 262-9. [Abstract] [Full-text]
10. The identification of chromosome abnormalities associated with the invasive phenotype of uveal melanoma in vitro.
    Clin Exp Metastasis, 22(2): 107-13. [Abstract] [Full-text]
11. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.
    Hum Pathol, 36(7): 724-31. [Abstract] [Full-text]
12. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Cancer, 104(4): 879-90. [Abstract] [Full-text]
13. Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing alpha(1,3)galactosyl epitopes.
    Cancer Immunol Immunother, 54(10): 999-1009. [Abstract] [Full-text]
14. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Int J Cancer, 117(1): 51-8. [Abstract] [Full-text]
15. Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies.
    Int J Cancer, 117(1): 59-67. [Abstract] [Full-text]
16. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
    Int J Cancer, 117(1): 114-22. [Abstract] [Full-text]
17. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice.
    Arch Ophthalmol, 123(8): 1088-94. [Abstract] [Full-text]
18. Effect of new antioxidant cysteinyl-flavanol conjugates on skin cancer cells.
    FEBS Lett, 579(20): 4219-25. [Abstract] [Full-text]
19. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Am J Ophthalmol, 140(2): 193-9. [Abstract] [Full-text]
20. Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas.
    J Invest Dermatol, 125(2): 318-22. [Abstract] [Full-text]
21. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.
    J Invest Dermatol, 125(2): 312-7. [Abstract] [Full-text]
22. Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells.
    J Invest Dermatol, 125(2): 307-11. [Abstract] [Full-text]
23. Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.
    J Invest Dermatol, 125(2): 201-6. [Abstract] [Full-text]
24. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Arch Dermatol, 141(8): 1016-22. [Abstract] [Full-text]
25. Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions.
    Arch Dermatol, 141(8): 1008-14. [Abstract] [Full-text]
26. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Arch Dermatol, 141(8): 998-1006. [Abstract] [Full-text]
27. Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.
    Oncology, 68(4): 341-9. [Abstract] [Full-text]
28. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin.
    J Agric Food Chem, 53(17): 6791-7. [Abstract] [Full-text]
29. Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome.
    J Clin Oncol, 23(24): 5779-87. [Abstract] [Full-text]
30. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.
    Cancer, 104(5): 1045-8. [Abstract] [Full-text]
31. Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma.
    Eur J Surg Oncol, 31(7): 778-83. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.